7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Staphylococcus aureus: the new adventures of a legendary pathogen.

      Cleveland Clinic journal of medicine
      Adult, Aged, Anti-Bacterial Agents, pharmacology, therapeutic use, Bacteremia, drug therapy, microbiology, Community-Acquired Infections, Cross Infection, Endocarditis, Fasciitis, Necrotizing, Female, Humans, Methicillin Resistance, Middle Aged, Risk Factors, Staphylococcal Infections, Staphylococcus aureus, pathogenicity, Vancomycin, Vancomycin Resistance

      Read this article at

      ScienceOpenPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Nosocomial infections with strains of methicillin-resistant Staphylococcus aureus (MRSA) began to emerge in the 1960s, are increasing in frequency, and tend to have worse outcomes than infections due to methicillin-susceptible S aureus. Community-associated MRSA infections emerged in the 1990s. Community-associated MRSA strains have up to now been epidemiologically and bacteriologically distinct from hospital-associated MRSA strains, but in a new twist, MRSA strains that have sofar been only community-associated are invading the hospital. Another worrisome trend is increasing resistance to vancomycin (Vancocin).

          Related collections

          Author and article information

          Comments

          Comment on this article